Sovereign Pharmaceuticals, LLC

FDA inspection history in Fort Worth, Texas, 2013 to 2023

6
Form 483s
2
Warning letters
1
Close-out

Every document, by year

  • Form 483
  • Warning letter
  • Close-out

2013: one warning letter; 2015: one Form 483; 2018: one Form 483; 2019: one Form 483 and one close-out letter; 2021: one Form 483; 2022: one warning letter and one Form 483; 2023: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2013–15One warning letter and one Form 483, at Fort Worth, Texas.
  2. 2018–23Five Form 483s, one close-out letter and one warning letter, at Fort Worth, Texas.
  3. 2022The longest 483 on file: 4 observations over 6 pages at Fort Worth, Texas.

Cited most

Across all Sovereign Pharmaceuticals observations on file

The complete Sovereign Pharmaceuticals file.

All 9 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$757$891

15% off buying them one by one

Sites

Documents

9 on file, newest first
DateDocumentPrice
2023-08-02483 Form 483$99
2022-10-05Warning letter Warning letter$99
2022-04-22483 Form 483$99
2021-09-01483 Form 483$99
2019-12-12483 Form 483$99
2019-06-04Close-out Close-out letter$99
2018-01-12483 Form 483$99
2015-08-21483 Form 483$99
2013-01-29Warning letter Warning letter$99

FEI number 3003229412 · most recent document Aug 2, 2023

About Sovereign Pharmaceuticals, LLC

How many FDA Form 483s has Sovereign Pharmaceuticals, LLC received?

FDA Intel has 6 Form 483s on file for Sovereign Pharmaceuticals, LLC; the most recent is dated Aug 2, 2023.

When was Sovereign Pharmaceuticals, LLC last inspected by FDA?

The most recent FDA inspection document on file for Sovereign Pharmaceuticals, LLC is a Form 483 dated Aug 2, 2023, for the site in Fort Worth, Texas.

What did FDA cite at Sovereign Pharmaceuticals, LLC?

The regulations cited most in the observations on file for Sovereign Pharmaceuticals, LLC are 21 CFR 211.22 (Responsibilities of quality control unit), 5 times; 21 CFR 211.160 (General requirements), 3 times; 21 CFR 211.100(a) (Written procedures; deviations), 1 time.

Has Sovereign Pharmaceuticals, LLC received an FDA warning letter?

Yes. FDA Intel has 2 FDA warning letters on file for Sovereign Pharmaceuticals, LLC; the most recent is dated Oct 5, 2022.